SCHEMBL6693656

SCHEMBL6693656

O=C(OCc1ccccc1)c1ccc(F)c(F)c1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.64
TDP1 Q9NUW8 4/20 0.64
SLC6A2 P23975 1/20 0.64
SLC6A3 Q01959 1/20 0.64
LMNA P02545 3/20 0.63
MAPT P10636 6/20 0.58
RAB9A P51151 5/20 0.58
ALDH1A1 P00352 5/20 0.58
NPC1 O15118 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
HPGD P15428 1/20 0.55
KDM4E B2RXH2 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
GAA P10253 1/20 0.50
MEN1 O00255 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2984951 0.88 TDP1 (0.60) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL662221 0.88 LMNA (0.64) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL20830732 0.86 TDP1 (0.58) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL3497492 0.86 KMT2A (0.58) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL20831011 0.86 TDP1 (0.58) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL4857410 0.86 KMT2A (0.58) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL15754802 0.86 KMT2A (0.58) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL20831009 0.86 TDP1 (0.58) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL8512033 0.85 SLC6A2 (0.57) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL3159761 0.85 KMT2A (0.57) KMT2ATDP1SLC6A2SLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021136805-A1 NOVEL PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-07-08 WO disclosed
EP-3798214-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2021-03-31 EP disclosed
EP-2917186-B1 ALKYL AMIDE-SUBSTITUTED PYRIMIDINE COMPOUNDS USEFUL IN THE MODULATION OF IL-12, IL-23 AND/OR IFN BRISTOL MYERS SQUIBB CO (US) 2017-10-18 EP disclosed
EP-0941998-B1 3,6-ketal macrolide antibiotics PFIZER PROD INC (US) 2004-09-01 EP disclosed
US-6043226-A TREATING BACTERIAL, PARASITIC AND PROTOZOAL INFECTIONS PFIZER INC. (US) 2000-03-28 US disclosed
CN-1244532-A 3,6-aldehyde acetal and enol ether large ring lactone vitamine PFIZER PRODUCTS CO (US) 2000-02-16 CN disclosed
EP-0941998-A2 3,6-ketal and enol ether macrolide antibiotics Pfizer Products Inc. (US) 1999-09-15 EP disclosed